The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study

Clinical trial NCT02390414 · COMPLETED

Trial details

NCT number: NCT02390414
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Myelodysplastic Syndromes (MDS)

Start date: 2011-05-01
Primary completion: 2020-09-01
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.